Trial Outcomes & Findings for Standardized Patient-Centered Medication Review in Home Hospice (NCT NCT03972163)

NCT ID: NCT03972163

Last Updated: 2025-05-21

Results Overview

Number of Completed Intervention Trainings

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

23 participants

Primary outcome timeframe

Baseline

Results posted on

2025-05-21

Participant Flow

Recruitment occurred at two hospice organizations where each hospice organization randomized 1 office to intervention and 1 office to control

Unit of analysis: hospice offices within hospice organizat

Participant milestones

Participant milestones
Measure
SPECTORx Educational Intervention
The program intervention is based on a combination of 3 existing, complementary, educational programs that, together, equip hospice staff to create a comprehensive, patient-centered, medication management care plan. STOPPFrail (Screening Tool of Older Persons Prescriptions): A screening tool used by clinicians with frail older adults with life-limiting illness to review medications "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing": Education resoruce used by clinicians to simplify and align medications with goals of care "Key Approaches to Support Informal Family Caregivers in Managing Medications": Education resource used by clinicians to support Family Care Givers (FCGs)
Attention Control
As the attention control, we will refer staff in control offices to the National Institute of Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support. NIA Medication Management - Active Comparator: As the attention control, we will refer staff in control offices to the National Institution on Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support.
Overall Study
STARTED
7 2
16 2
Overall Study
Hospice 1
5 1
12 1
Overall Study
Hospice 2
2 1
4 1
Overall Study
COMPLETED
7 2
15 2
Overall Study
NOT COMPLETED
0 0
1 0

Reasons for withdrawal

Reasons for withdrawal
Measure
SPECTORx Educational Intervention
The program intervention is based on a combination of 3 existing, complementary, educational programs that, together, equip hospice staff to create a comprehensive, patient-centered, medication management care plan. STOPPFrail (Screening Tool of Older Persons Prescriptions): A screening tool used by clinicians with frail older adults with life-limiting illness to review medications "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing": Education resoruce used by clinicians to simplify and align medications with goals of care "Key Approaches to Support Informal Family Caregivers in Managing Medications": Education resource used by clinicians to support Family Care Givers (FCGs)
Attention Control
As the attention control, we will refer staff in control offices to the National Institute of Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support. NIA Medication Management - Active Comparator: As the attention control, we will refer staff in control offices to the National Institution on Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support.
Overall Study
Death
0
1

Baseline Characteristics

Demographic data for Caregiver Intervention group missing/not available for select participants

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Patients: SPECTORx Educational Intervention
n=7 Participants
The program intervention is based on a combination of 3 existing, complementary, educational programs that, together, equip hospice staff to create a comprehensive, patient-centered, medication management care plan. STOPPFrail (Screening Tool of Older Persons Prescriptions): A screening tool used by clinicians with frail older adults with life-limiting illness to review medications "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing": Education resoruce used by clinicians to simplify and align medications with goals of care "Key Approaches to Support Informal Family Caregivers in Managing Medications": Education resource used by clinicians to support Family Care Givers (FCGs)
Patients: Attention Control
n=15 Participants
As the attention control, we will refer staff in control offices to the National Institute of Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support. NIA Medication Management - Active Comparator: As the attention control, we will refer staff in control offices to the National Institution on Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support.
Caregivers SPECTORx Educational Intervention
n=7 Participants
The program intervention is based on a combination of 3 existing, complementary, educational programs that, together, equip hospice staff to create a comprehensive, patient-centered, medication management care plan. STOPPFrail (Screening Tool of Older Persons Prescriptions): A screening tool used by clinicians with frail older adults with life-limiting illness to review medications "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing": Education resoruce used by clinicians to simplify and align medications with goals of care "Key Approaches to Support Informal Family Caregivers in Managing Medications": Education resource used by clinicians to support Family Care Givers (FCGs)
Caregivers: Attention Control
n=15 Participants
As the attention control, we will refer staff in control offices to the National Institute of Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support. NIA Medication Management - Active Comparator: As the attention control, we will refer staff in control offices to the National Institution on Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support.
Total
n=44 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=7 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
0 Participants
n=15 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
0 Participants
n=6 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
0 Participants
n=15 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
0 Participants
n=43 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
Age, Categorical
Between 18 and 65 years
0 Participants
n=7 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
0 Participants
n=15 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
3 Participants
n=6 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
8 Participants
n=15 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
11 Participants
n=43 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
Age, Categorical
>=65 years
7 Participants
n=7 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
15 Participants
n=15 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
3 Participants
n=6 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
7 Participants
n=15 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
32 Participants
n=43 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
Age, Continuous
83.6 years
STANDARD_DEVIATION 14.5 • n=7 Participants • Demographic data for Caregiver Intervention group missing/not available.
79.5 years
STANDARD_DEVIATION 10.3 • n=15 Participants • Demographic data for Caregiver Intervention group missing/not available.
80.8 years
STANDARD_DEVIATION 11.6 • n=22 Participants • Demographic data for Caregiver Intervention group missing/not available.
Sex: Female, Male
Female
4 Participants
n=7 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
11 Participants
n=15 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
4 Participants
n=6 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
13 Participants
n=15 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
32 Participants
n=43 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
Sex: Female, Male
Male
3 Participants
n=7 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
4 Participants
n=15 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
2 Participants
n=6 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
2 Participants
n=15 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
11 Participants
n=43 Participants • Demographic data for Caregiver Intervention group missing/not available for select participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
n=7 Participants
1 Participants
n=15 Participants
0 Participants
n=7 Participants
1 Participants
n=15 Participants
2 Participants
n=44 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
7 Participants
n=7 Participants
14 Participants
n=15 Participants
6 Participants
n=7 Participants
14 Participants
n=15 Participants
41 Participants
n=44 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=7 Participants
0 Participants
n=15 Participants
1 Participants
n=7 Participants
0 Participants
n=15 Participants
1 Participants
n=44 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=7 Participants
0 Participants
n=15 Participants
0 Participants
n=7 Participants
0 Participants
n=15 Participants
0 Participants
n=44 Participants
Race (NIH/OMB)
Asian
0 Participants
n=7 Participants
1 Participants
n=15 Participants
1 Participants
n=7 Participants
0 Participants
n=15 Participants
2 Participants
n=44 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=7 Participants
0 Participants
n=15 Participants
0 Participants
n=7 Participants
0 Participants
n=15 Participants
0 Participants
n=44 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=7 Participants
0 Participants
n=15 Participants
1 Participants
n=7 Participants
0 Participants
n=15 Participants
2 Participants
n=44 Participants
Race (NIH/OMB)
White
6 Participants
n=7 Participants
13 Participants
n=15 Participants
5 Participants
n=7 Participants
13 Participants
n=15 Participants
37 Participants
n=44 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=7 Participants
0 Participants
n=15 Participants
0 Participants
n=7 Participants
1 Participants
n=15 Participants
1 Participants
n=44 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=7 Participants
1 Participants
n=15 Participants
0 Participants
n=7 Participants
1 Participants
n=15 Participants
2 Participants
n=44 Participants
Region of Enrollment
United States
7 participants
n=7 Participants
15 participants
n=15 Participants
7 participants
n=7 Participants
15 participants
n=15 Participants
22 participants
n=44 Participants

PRIMARY outcome

Timeframe: Baseline

Population: Control group did not offer intervention training.

Number of Completed Intervention Trainings

Outcome measures

Outcome measures
Measure
SPECTORx Educational Intervention
n=17 Participants
The program intervention is based on a combination of 3 existing, complementary, educational programs that, together, equip hospice staff to create a comprehensive, patient-centered, medication management care plan. STOPPFrail (Screening Tool of Older Persons Prescriptions): A screening tool used by clinicians with frail older adults with life-limiting illness to review medications "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing": Education resoruce used by clinicians to simplify and align medications with goals of care "Key Approaches to Support Informal Family Caregivers in Managing Medications": Education resource used by clinicians to support Family Care Givers (FCGs)
Attention Control
As the attention control, we will refer staff in control offices to the National Institute of Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support. NIA Medication Management - Active Comparator: As the attention control, we will refer staff in control offices to the National Institution on Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support.
Intervention Training Completion by Hospice Staff
17 Participants
0 Participants

PRIMARY outcome

Timeframe: 2 weeks prior to enrollment

Population: Screened dyads who met eligibility criteria

Number of Eligible Dyad Participants (i.e. participant = 1 dyad) screened for potential eligibility to inform subsequent eligibility criteria to obtain a sufficient study population.

Outcome measures

Outcome measures
Measure
SPECTORx Educational Intervention
n=77 Dyads
The program intervention is based on a combination of 3 existing, complementary, educational programs that, together, equip hospice staff to create a comprehensive, patient-centered, medication management care plan. STOPPFrail (Screening Tool of Older Persons Prescriptions): A screening tool used by clinicians with frail older adults with life-limiting illness to review medications "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing": Education resoruce used by clinicians to simplify and align medications with goals of care "Key Approaches to Support Informal Family Caregivers in Managing Medications": Education resource used by clinicians to support Family Care Givers (FCGs)
Attention Control
n=184 Dyads
As the attention control, we will refer staff in control offices to the National Institute of Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support. NIA Medication Management - Active Comparator: As the attention control, we will refer staff in control offices to the National Institution on Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support.
Patient and Family Caregiver Eligibility Screens
77 Dyads
184 Dyads

PRIMARY outcome

Timeframe: Baseline

Population: number of participants who consented to enrollment and survived to data collection; 1 patient died before data collection so dyad was removed

Number of Patients and Family Caregivers who enrolled

Outcome measures

Outcome measures
Measure
SPECTORx Educational Intervention
n=7 Dyads
The program intervention is based on a combination of 3 existing, complementary, educational programs that, together, equip hospice staff to create a comprehensive, patient-centered, medication management care plan. STOPPFrail (Screening Tool of Older Persons Prescriptions): A screening tool used by clinicians with frail older adults with life-limiting illness to review medications "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing": Education resoruce used by clinicians to simplify and align medications with goals of care "Key Approaches to Support Informal Family Caregivers in Managing Medications": Education resource used by clinicians to support Family Care Givers (FCGs)
Attention Control
n=15 Dyads
As the attention control, we will refer staff in control offices to the National Institute of Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support. NIA Medication Management - Active Comparator: As the attention control, we will refer staff in control offices to the National Institution on Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support.
Patient and Family Caregiver Enrollment
7 Dyads
15 Dyads

PRIMARY outcome

Timeframe: Baseline

Population: number of participants who consented to enrollment and survived to data collection; 1 patient died before data collection so dyad was removed

Number of Dyads who completed the Medication Regimen Complexity Score at Baseline

Outcome measures

Outcome measures
Measure
SPECTORx Educational Intervention
n=7 Dyads
The program intervention is based on a combination of 3 existing, complementary, educational programs that, together, equip hospice staff to create a comprehensive, patient-centered, medication management care plan. STOPPFrail (Screening Tool of Older Persons Prescriptions): A screening tool used by clinicians with frail older adults with life-limiting illness to review medications "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing": Education resoruce used by clinicians to simplify and align medications with goals of care "Key Approaches to Support Informal Family Caregivers in Managing Medications": Education resource used by clinicians to support Family Care Givers (FCGs)
Attention Control
n=15 Dyads
As the attention control, we will refer staff in control offices to the National Institute of Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support. NIA Medication Management - Active Comparator: As the attention control, we will refer staff in control offices to the National Institution on Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support.
Completion of Primary Patient Outcome--Retention
7 Dyads
15 Dyads

SECONDARY outcome

Timeframe: Baseline, 2, 4, 6, 8 12, 16, 20, 24 weeks(or death)

Population: number of participants who consented to enrollment and survived to data collection; 1 patient died before data collection so dyad was removed

The 24-item Family Caregiver Medication Administration Hassle Scale has four subscales: Information Seeking/Sharing, Safety Issues, Scheduling Logistics, and Polypharmacy. The theoretical range of the scores across 4 subscales is 0 to 120. Higher scores indicate greater burden. Overall scale reliability is .95.

Outcome measures

Outcome measures
Measure
SPECTORx Educational Intervention
n=7 Participants
The program intervention is based on a combination of 3 existing, complementary, educational programs that, together, equip hospice staff to create a comprehensive, patient-centered, medication management care plan. STOPPFrail (Screening Tool of Older Persons Prescriptions): A screening tool used by clinicians with frail older adults with life-limiting illness to review medications "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing": Education resoruce used by clinicians to simplify and align medications with goals of care "Key Approaches to Support Informal Family Caregivers in Managing Medications": Education resource used by clinicians to support Family Care Givers (FCGs)
Attention Control
n=15 Participants
As the attention control, we will refer staff in control offices to the National Institute of Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support. NIA Medication Management - Active Comparator: As the attention control, we will refer staff in control offices to the National Institution on Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support.
Family Caregiver Medication Administration Hassle Scale
12 weeks
10 score on a scale
33.3 score on a scale
Standard Deviation 3.9
Family Caregiver Medication Administration Hassle Scale
16 weeks
7 score on a scale
30 score on a scale
Family Caregiver Medication Administration Hassle Scale
6 weeks
22.5 score on a scale
Standard Deviation 13.4
26.8 score on a scale
Standard Deviation 12.2
Family Caregiver Medication Administration Hassle Scale
Baseline
13.6 score on a scale
Standard Deviation 21.1
31 score on a scale
Standard Deviation 16.7
Family Caregiver Medication Administration Hassle Scale
2 weeks
19.7 score on a scale
Standard Deviation 30.6
37 score on a scale
Standard Deviation 17.5
Family Caregiver Medication Administration Hassle Scale
4 weeks
16.7 score on a scale
Standard Deviation 19.5
36.1 score on a scale
Standard Deviation 17.5
Family Caregiver Medication Administration Hassle Scale
8 weeks
21.5 score on a scale
Standard Deviation 23.3
26.5 score on a scale
Standard Deviation 9.5
Family Caregiver Medication Administration Hassle Scale
20 weeks
47 score on a scale
Family Caregiver Medication Administration Hassle Scale
24 weeks (or death)
21 score on a scale

SECONDARY outcome

Timeframe: Baseline, 2, 4, 6, 8, 12, 16, 20, 24 weeks(or death)

Population: number of participants who consented to enrollment and survived to data collection; 1 patient died before data collection so dyad was removed

Medication Regimen Complexity Index (MCRI) will characterize patients' chronic disease and preventive medication regimens (i.e. drugs initiated prior to hospice admission, not End of Life (EOL) symptom medications \[e.g. haloperidol\] because these increase over time). MRCI score weights dosage form, dosing frequency and administration instructions. Minimum MRCI is 1.5 \[a single tablet once a day\] and maximum score increases with medication number. Higher scores indicate greater complexity. MRCI score of 0 indicates no medication use. There is no established maximum score.

Outcome measures

Outcome measures
Measure
SPECTORx Educational Intervention
n=7 Participants
The program intervention is based on a combination of 3 existing, complementary, educational programs that, together, equip hospice staff to create a comprehensive, patient-centered, medication management care plan. STOPPFrail (Screening Tool of Older Persons Prescriptions): A screening tool used by clinicians with frail older adults with life-limiting illness to review medications "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing": Education resoruce used by clinicians to simplify and align medications with goals of care "Key Approaches to Support Informal Family Caregivers in Managing Medications": Education resource used by clinicians to support Family Care Givers (FCGs)
Attention Control
n=15 Participants
As the attention control, we will refer staff in control offices to the National Institute of Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support. NIA Medication Management - Active Comparator: As the attention control, we will refer staff in control offices to the National Institution on Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support.
Medication Regimen Complexity Index
baseline
39 score on a scale
Standard Deviation 8.8
23.5 score on a scale
Standard Deviation 8.2
Medication Regimen Complexity Index
2 weeks
43.5 score on a scale
Standard Deviation 13.1
31.0 score on a scale
Standard Deviation 10.3
Medication Regimen Complexity Index
4 weeks
43.3 score on a scale
Standard Deviation 12.9
32.5 score on a scale
Standard Deviation 11.2
Medication Regimen Complexity Index
6 weeks
46.4 score on a scale
Standard Deviation 13.9
33.6 score on a scale
Standard Deviation 12.8
Medication Regimen Complexity Index
8 weeks
44 score on a scale
Standard Deviation 19.4
31.1 score on a scale
Standard Deviation 12.4
Medication Regimen Complexity Index
12 weeks
43.8 score on a scale
Standard Deviation 21.1
26.8 score on a scale
Standard Deviation 12.5
Medication Regimen Complexity Index
16 weeks
51.1 score on a scale
Standard Deviation 11.3
29 score on a scale
Standard Deviation 15.2
Medication Regimen Complexity Index
20 weeks
52.3 score on a scale
Standard Deviation 12.3
33.4 score on a scale
Standard Deviation 15.0
Medication Regimen Complexity Index
24 weeks (or death)
47 score on a scale
Standard Deviation 16.9
23.5 score on a scale
Standard Deviation 22.6

SECONDARY outcome

Timeframe: Week 2, 4, 6, 8, 12, 16, 20, 24

Population: Data on Potential Adverse Drug Events for patient participants

Hospitalizations and Emergency Department (ED) visits will be abstracted from the hospice record. Potential Adverse Drug Event (ADE)s and Adverse Drug Withdrawal Events (ADWEs) will be determined from medical record review

Outcome measures

Outcome measures
Measure
SPECTORx Educational Intervention
n=7 Participants
The program intervention is based on a combination of 3 existing, complementary, educational programs that, together, equip hospice staff to create a comprehensive, patient-centered, medication management care plan. STOPPFrail (Screening Tool of Older Persons Prescriptions): A screening tool used by clinicians with frail older adults with life-limiting illness to review medications "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing": Education resoruce used by clinicians to simplify and align medications with goals of care "Key Approaches to Support Informal Family Caregivers in Managing Medications": Education resource used by clinicians to support Family Care Givers (FCGs)
Attention Control
n=15 Participants
As the attention control, we will refer staff in control offices to the National Institute of Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support. NIA Medication Management - Active Comparator: As the attention control, we will refer staff in control offices to the National Institution on Aging (NIA)'s website on "Medicines and Medication Management" to review content and materials for use in Family Care Giver (FCG) support.
Potential Adverse Event
Baseline
0 Adverse Events
0 Adverse Events
Potential Adverse Event
Week 2
0 Adverse Events
0 Adverse Events
Potential Adverse Event
Week 4
0 Adverse Events
0 Adverse Events
Potential Adverse Event
Week 6
0 Adverse Events
0 Adverse Events
Potential Adverse Event
week 8
0 Adverse Events
0 Adverse Events
Potential Adverse Event
Week 12
0 Adverse Events
0 Adverse Events
Potential Adverse Event
Week 16
0 Adverse Events
0 Adverse Events
Potential Adverse Event
Week 20
0 Adverse Events
0 Adverse Events
Potential Adverse Event
Week 24
0 Adverse Events
0 Adverse Events

Adverse Events

Patients: SPECTORx Educational Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 2 deaths

Patients: Attention Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 10 deaths

Family Caregivers: SPECTORx Educational Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Family Caregivers: Attention Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Jennifer Tjia, Principal Investigator

UMass Chan Medical School

Phone: 774-455-3538

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place